By the Numbers

September 2011
Pharmaceutical Representative;Sep2011, Vol. 41 Issue 9, p12
Several charts related to the pharmaceutical industry in the U.S. are presented including the average drug sample acceptance rate, drug sample acceptance preferences by site size, and drug sample acceptance preferences by patient value.


Related Articles

  • Market Pulse.  // Pharmaceutical Executive;Aug2000, Vol. 20 Issue 8, p112 

    Presents graphical representations of the top five pharmaceutical companies and prescription brands in the United States in 1999.

  • New Drugs in the Pipeline.  // CenterWatch Monthly;Mar2014, Vol. 21 Issue 3, p22 

    A chart is presented that lists new drugs in the pharmaceutical companies in the U.S. including veliparib from Abbvie Inc., Alzheimer's disease (AZD)3293 from AstraZeneca PLC and dendritic cell therapy from DiaVac's.

  • By the Numbers.  // Pharmaceutical Representative;Jun2010, Vol. 40 Issue 6, p12 

    Several charts are presented showing the marketing performance of several pharmaceutical companies in the U.S. including Pfizer Inc., Sanofi-Aventis, and Novartis AG, along with the leading sales of therapeutics and pharmaceutical products.

  • FDA Approvals In August.  // BioWorld Insight;9/13/2010, Vol. 18 Issue 37, p7 

    A chart is presented depicting the approval of various drugs from several pharmaceutical companies bt the U.S. Food and Drug Administration.

  • FDA Submissions, Approvals & Other Actions: August 2010.  // BioWorld Insight;9/13/2010, Vol. 18 Issue 37, p16 

    A chart is presented depicting the U.S. Food and Drug Administration (FDA) submissions, and approvals of drugs for various conditions from several pharmaceutical companies that are outside the U.S. including EpiCept Corp., MedImmune Inc., and Lux Biosciences inc.

  • FDA Approvals In June.  // BioWorld Insight;7/11/2011, Vol. 19 Issue 28, p7 

    A chart is presented depicting the approved drugs of the Federal Drug Administration for June from various pharmaceutical companies with their corresponding indications including Creon from Abbott, Oxecta from Acura Pharmaceuticals Inc. and Istodax from Celgene Corp.

  • Non-U.S. Clinical Trials & Regulatory Actions: December 2011.  // BioWorld Insight;1/23/2012, Vol. 20 Issue 4, p26 

    A table is presented which lists the pharmaceutical companies, along with their products that are under the non-U.S. clinical trials as of December 2011, including Advaxis Inc.'s ADXS-HPV, InterMune Inc.'s Esbriet, and Novartis AG's Lucentis.

  • Drug & Device Pipeline News.  // CenterWatch Weekly;3/10/2014, Vol. 18 Issue 10, p10 

    A chart is presented that lists the drugs and devices offered by pharmaceutical companies as of March 2014 including the diseases they treat, status and sponsor contact.

  • FEBRUARY UPDATES.  // Monthly Prescribing Reference;Feb2012, Vol. 28 Issue 2, pA33 

    A table is presented that lists several updates of February 2012 from the pharmaceutical sector including drug monographs, manufacturer section changes and added products.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics